Reyon Pharmaceutical Co Ltd (102460) — Free Cash Flow Generation Index
Reyon Pharmaceutical Co Ltd (102460) has a Free Cash Flow Generation Index of -0.76x as of March 2025. Free cash flow of ₩-1.83 Billion represents -1% of operating cash flow (₩2.41 Billion). Explore 102460 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Reyon Pharmaceutical Co Ltd Free Cash Flow Generation Index (2008–2023)
Historical FCF Generation Index trend for Reyon Pharmaceutical Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see Reyon Pharmaceutical Co Ltd (102460) cash flow conversion.
Annual Free Cash Flow Generation for Reyon Pharmaceutical Co Ltd (2008–2023)
Year-by-year Free Cash Flow Generation Index for Reyon Pharmaceutical Co Ltd. Check Reyon Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -2.34x | ₩-20.23 Billion | ₩8.65 Billion | ₩28.87 Billion | ▲ +62.5% |
| 2022 | -6.23x | ₩-54.40 Billion | ₩8.73 Billion | ₩63.13 Billion | ▲ +30.9% |
| 2021 | -9.01x | ₩-105.31 Billion | ₩11.68 Billion | ₩116.98 Billion | ▲ +13.1% |
| 2020 | -10.37x | ₩-47.71 Billion | ₩4.60 Billion | ₩52.31 Billion | ▼ -324.7% |
| 2018 | -2.44x | ₩-27.97 Billion | ₩11.45 Billion | ₩39.17 Billion | ▼ -439.1% |
| 2017 | 0.72x | ₩12.08 Billion | ₩16.76 Billion | ₩4.14 Billion | ▼ -46.2% |
| 2016 | 1.34x | ₩12.68 Billion | ₩9.47 Billion | ₩3.21 Billion | ▲ +22.0% |
| 2012 | 1.10x | ₩27.07 Billion | ₩24.65 Billion | ₩2.42 Billion | ▼ -5.1% |
| 2011 | 1.16x | ₩17.76 Billion | ₩15.34 Billion | ₩2.42 Billion | ▼ -0.9% |
| 2009 | 1.17x | ₩10.14 Billion | ₩8.68 Billion | ₩1.46 Billion | ▼ -13.1% |
| 2008 | 1.34x | ₩8.04 Billion | ₩5.99 Billion | ₩2.06 Billion | — |